Ian Barr

Dr. Ian Barr

orcid

Research Focus & Metrics

Academic Career Length

48Years (1979-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2013 in Science
Verified
Journal Article
Closed access
PDF file
BKBjörn F. Koel
Björn F. Koel
DBDavid Burke
David Burke
TBTheo M. Bestebroer
Theo M. Bestebroer
SVStefan van der Vliet
Stefan van der Vliet
GZGerben C. M. Zondag
Gerben C. M. Zondag
DSDerek Smith
Derek Smith
Flu Drift Limited: Five antigenic sites in the virus surface hemagglutinin protein, which together comprise 131 amino acid positions, are thought to determine the full scope of antigenic drift of influenza A virus. Koel et al. (p. 976 ) show that major antigenic change can be caused by single amino acid substitutions. These single substitutions substantially skew the way the immune system “sees” the virus. All substitutions of importance are located next to the receptor-binding site in the hemagglutinin. Because there are few positions of importance for antigenic drift, there are strict biophysical limitations to the substitutions at these positions, which restricts the number of new antigenic drift variants at any point in time. Thus, the evolution of influenza virus may be more predictable than previously thought.

18 April 2008 in Science
Verified
Journal Article
Closed access
PDF file
CRColin Russell
Colin Russell
TJTerry C. Jones
Terry C. Jones
Ian BarrIan Barr
Ian Barr
NCNancy J. Cox
Nancy J. Cox
RGRebecca J. Garten
Rebecca J. Garten
DSDerek Smith
Derek Smith
Antigenic and genetic analysis of the hemagglutinin of ∼13,000 human influenza A (H3N2) viruses from six continents during 2002–2007 revealed that there was continuous circulation in east and Southeast Asia (E-SE Asia) via a region-wide network of temporally overlapping epidemics and that epidemics in the temperate regions were seeded from this network each year. Seed strains generally first reached Oceania, North America, and Europe, and later South America. This evidence suggests that once A (H3N2) viruses leave E-SE Asia, they are unlikely to contribute to long-term viral evolution. If the trends observed during this period are an accurate representation of overall patterns of spread, then the antigenic characteristics of A (H3N2) viruses outside E-SE Asia may be forecast each year based on surveillance within E-SE Asia, with consequent improvements to vaccine strain selection.

8 June 2015 in Nature
Verified
Journal Article
Open access
PDF file
TBTrevor Bedford
Trevor Bedford
SRSteven Riley
Steven Riley
Ian BarrIan Barr
Ian Barr
SBShobha Broor
Shobha Broor
MCMandeep Chadha
Mandeep Chadha
CRColin Russell
Colin Russell
The analysis of more than 9,000 haemagglutinin sequences of human seasonal influenza viruses over a 12-year time period shows that the global circulation patterns of A/H1N1 and B viruses are different from those of the well characterised A/H3N2 viruses; in particular the A/H1N1 and B viruses are shown to persist locally across several seasons and do not display the same degree of global movement as the H3N2 viruses. An analysis of more than 9,000 haemagglutinin sequences of human seasonal influenza viruses over a 12-year time period (2000–2012) shows that the global circulation patterns of A/H1N1 and B viruses differ markedly from those of the well characterized A/H3N2 viruses. In particular the H1N1 viruses persist locally across multiple seasons and don't show the same degree of global movement as the H3N2 viruses. The authors correlate these dynamics with rates of antigenic evolution, age of infection and size of epidemics. Understanding the spatiotemporal patterns of emergence and circulation of new human seasonal influenza virus variants is a key scientific and public health challenge. The global circulation patterns of influenza A/H3N2 viruses are well characterized1,2,3,4,5,6,7, but the patterns of A/H1N1 and B viruses have remained largely unexplored. Here we show that the global circulation patterns of A/H1N1 (up to 2009), B/Victoria, and B/Yamagata viruses differ substantially from those of A/H3N2 viruses, on the basis of analyses of 9,604 haemagglutinin sequences of human seasonal influenza viruses from 2000 to 2012. Whereas genetic variants of A/H3N2 viruses did not persist locally between epidemics and were reseeded from East and Southeast Asia, genetic variants of A/H1N1 and B viruses persisted across several seasons and exhibited complex global dynamics with East and Southeast Asia playing a limited role in disseminating new variants. The less frequent global movement of influenza A/H1N1 and B viruses coincided with slower rates of antigenic evolution, lower ages of infection, and smaller, less frequent epidemics compared to A/H3N2 viruses. Detailed epidemic models support differences in age of infection, combined with the less frequent travel of children, as probable drivers of the differences in the patterns of global circulation, suggesting a complex interaction between virus evolution, epidemiology, and human behaviour.

21 November 2014 in Science
Verified
Journal Article
Closed access
PDF file
JFJ. M. Fonville
J. M. Fonville
SWS. H. Wilks
S. H. Wilks
SJS. L. James
S. L. James
AFAnnette Fox
Annette Fox
MVM. Ventresca
M. Ventresca
DSDerek Smith
Derek Smith
We introduce the antibody landscape, a method for the quantitative analysis of antibody-mediated immunity to antigenically variable pathogens, achieved by accounting for antigenic variation among pathogen strains. We generated antibody landscapes to study immune profiles covering 43 years of influenza A/H3N2 virus evolution for 69 individuals monitored for infection over 6 years and for 225 individuals pre- and postvaccination. Upon infection and vaccination, titers increased broadly, including previously encountered viruses far beyond the extent of cross-reactivity observed after a primary infection. We explored implications for vaccination and found that the use of an antigenically advanced virus had the dual benefit of inducing antibodies against both advanced and previous antigenic clusters. These results indicate that preemptive vaccine updates may improve influenza vaccine efficacy in previously exposed individuals.

24 May 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
JEJohn-Sebastian Eden
John-Sebastian Eden
CSChisha Sikazwe
Chisha Sikazwe
RXRuopeng Xie
Ruopeng Xie
YDYi-Mo Deng
Yi-Mo Deng
SSSheena Sullivan
Sheena Sullivan
TTTyna Tran
Tyna Tran
Human respiratory syncytial virus (RSV) is an important cause of acute respiratory infection with the most severe disease in the young and elderly. Non-pharmaceutical interventions and travel restrictions for controlling COVID-19 have impacted the circulation of most respiratory viruses including RSV globally, particularly in Australia, where during 2020 the normal winter epidemics were notably absent. However, in late 2020, unprecedented widespread RSV outbreaks occurred, beginning in spring, and extending into summer across two widely separated regions of the Australian continent, New South Wales (NSW) and Australian Capital Territory (ACT) in the east, and Western Australia. Through genomic sequencing we reveal a major reduction in RSV genetic diversity following COVID-19 emergence with two genetically distinct RSV-A clades circulating cryptically, likely localised for several months prior to an epidemic surge in cases upon relaxation of COVID-19 control measures. The NSW/ACT clade subsequently spread to the neighbouring state of Victoria and to cause extensive outbreaks and hospitalisations in early 2021. These findings highlight the need for continued surveillance and sequencing of RSV and other respiratory viruses during and after the COVID-19 pandemic, as mitigation measures may disrupt seasonal patterns, causing larger or more severe outbreaks.

16 January 2015 in eLife
Verified
Journal Article
Open access
DVDhanasekaran Vijaykrishna
Dhanasekaran Vijaykrishna
EHEdward Holmes
Edward Holmes
UJUdayan Joseph
Udayan Joseph
MFMathieu Fourment
Mathieu Fourment
YSYvonne Cf Su
Yvonne Cf Su
Ian BarrIan Barr
Ian Barr
A complex interplay of viral, host, and ecological factors shapes the spatio-temporal incidence and evolution of human influenza viruses. Although considerable attention has been paid to influenza A viruses, a lack of equivalent data means that an integrated evolutionary and epidemiological framework has until now not been available for influenza B viruses, despite their significant disease burden. Through the analysis of over 900 full genomes from an epidemiological collection of more than 26,000 strains from Australia and New Zealand, we reveal fundamental differences in the phylodynamics of the two co-circulating lineages of influenza B virus (Victoria and Yamagata), showing that their individual dynamics are determined by a complex relationship between virus transmission, age of infection, and receptor binding preference. In sum, this work identifies new factors that are important determinants of influenza B evolution and epidemiology.